Profil
Dawn Schottlandt worked as VP-Investor Relations & Corporate Communications at ArQule, Inc. from 2015 to 2018 and at Chiasma, Inc. from 2019 to 2020.
She completed her undergraduate degree at Boston College.
Anciens postes connus de Dawn Schottlandt
| Sociétés | Poste | Fin |
|---|---|---|
| CHIASMA, INC. | Investor Relations Contact | 01/07/2020 |
| ARQULE, INC. | Investor Relations Contact | 01/01/2018 |
Formation de Dawn Schottlandt
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
